Korro Bio, Inc. (KRRO) — Financial Flexibility Index
Korro Bio, Inc. (KRRO) has a Financial Flexibility Index of -0.25x as of March 2026. Free cash flow of $-16.05 Million (operating CF $-16.07 Million minus capex $21.00K) represents 0% of total liabilities ($63.99 Million). Also explore KRRO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Korro Bio, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Korro Bio, Inc. across 9 annual periods. Check KRRO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Korro Bio, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Korro Bio, Inc.. For the full company profile including market capitalisation, see market value of Korro Bio, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.26x | $-78.04 Million | $-78.56 Million | $62.07 Million | ▼ -96.3% |
| 2024 | -0.64x | $-42.17 Million | $-60.07 Million | $65.83 Million | ▲ +44.2% |
| 2023 | -1.15x | $-59.45 Million | $-67.28 Million | $51.75 Million | ▼ -309.8% |
| 2022 | -0.28x | $-48.43 Million | $-53.65 Million | $172.77 Million | ▲ +44.7% |
| 2021 | -0.51x | $-27.65 Million | $-32.09 Million | $54.53 Million | ▲ +4.9% |
| 2020 | -0.53x | $-38.52 Million | $-45.19 Million | $72.23 Million | ▼ -184.4% |
| 2019 | 0.63x | $35.28 Million | $34.22 Million | $55.86 Million | ▲ +439.1% |
| 2018 | -0.19x | $-16.59 Million | $-17.02 Million | $89.06 Million | ▲ +27.8% |
| 2017 | -0.26x | $-12.75 Million | $-14.61 Million | $49.43 Million | — |